FDA Approved: ERLEADA — Supplemental Application (Janssen Products, LP)

View source ↗

Summary

FDA approved a supplemental application for ERLEADA (apalutamide) submitted by Janssen Products, LP. The approval expands the drug's label for prostate cancer i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-sensitive Prostate Cancer
• Non-metastatic Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• ERLEADA (apalutamide)

Snippet

SUPPL AP for ERLEADA (APALUTAMIDE)